메뉴 건너뛰기




Volumn 31, Issue 3, 2011, Pages 183-190

Role of intravitreal bevacizumab in adult onset Coats' disease

Author keywords

Adult onset Coats' disease; Intravitreal bevacizumab; Macular edema; Subfoveal exudation; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB;

EID: 79959761557     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-011-9436-x     Document Type: Article
Times cited : (23)

References (19)
  • 1
    • 0035024272 scopus 로고    scopus 로고
    • Clinical variations and complications of Coats disease in 150 cases: The 2000 Sanford Gifford Memorial Lecture
    • DOI 10.1016/S0002-9394(00)00883-7, PII S0002939400008837
    • Shields JA, Shields CL, Honavar SG, Demirci H (2001) Clinical variations and complications of Coats disease in 150 cases. The 2000 Sanford Gifford memorial lecture. Am J Ophthalmol 131:561-571 (Pubitemid 32422112)
    • (2001) American Journal of Ophthalmology , vol.131 , Issue.5 , pp. 561-571
    • Shields, J.A.1    Shields, C.L.2    Honavar, S.G.3    Demirci, H.4
  • 2
    • 0035003144 scopus 로고    scopus 로고
    • Classification and management of Coats disease: The 2000 Proctor Lecture
    • DOI 10.1016/S0002-9394(01)00896-0, PII S0002939401008960
    • Shields JA, Shields CL, Honavar SG, Demirci H, Cater J (2001) Classification and management of Coats disease. The 2000 proctor lecture. Am J Ophthalmol 131:572-583 (Pubitemid 32422113)
    • (2001) American Journal of Ophthalmology , vol.131 , Issue.5 , pp. 572-583
    • Shields, J.A.1    Shields, C.L.2    Honavar, S.G.3    Demirci, H.4    Cater, J.5
  • 4
    • 77952194133 scopus 로고    scopus 로고
    • Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: Effects and complications
    • Othman IS, Moussa M, Bouhaimed M (2010) Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications. Br J Ophthalmol 94:606-610
    • (2010) Br J Ophthalmol , vol.94 , pp. 606-610
    • Othman, I.S.1    Moussa, M.2    Bouhaimed, M.3
  • 5
    • 33646229534 scopus 로고    scopus 로고
    • Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide
    • Jarin RR, Teoh SCB, Lim TH (2006) Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide. Eye 20:163e5
    • (2006) Eye , vol.20
    • Jarin, R.R.1    Teoh, S.C.B.2    Lim, T.H.3
  • 8
    • 45449108608 scopus 로고    scopus 로고
    • Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease
    • DOI 10.1016/j.jaapos.2008.01.009, PII S1091853108000372
    • Cakir M, Cekic O, Yilmaz F (2008) Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS 12:309-311 (Pubitemid 351853463)
    • (2008) Journal of AAPOS , vol.12 , Issue.3 , pp. 309-311
    • Cakir, M.1    Cekic, O.2    Yilmaz, O.F.3
  • 9
    • 69449102693 scopus 로고    scopus 로고
    • Coats' disease: Treatment with intravitreal bevacizumab and laser photocoagulation
    • Stergiou PK, Symeonidis C, Dimitrakos SA (2009) Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol 87:687-688
    • (2009) Acta Ophthalmol , vol.87 , pp. 687-688
    • Stergiou, P.K.1    Symeonidis, C.2    Dimitrakos, S.A.3
  • 10
    • 42049110754 scopus 로고    scopus 로고
    • Management of Coats disease with bevacizumab in 2 patients
    • DOI 10.3129/I08-028
    • Venkatesh P, Mandal S, Garg S (2008) Management of Coats' disease with bevacizumab in 2 patients. Can J Ophthalmol 43:245-246 (Pubitemid 351518186)
    • (2008) Canadian Journal of Ophthalmology , vol.43 , Issue.2 , pp. 245-246
    • Venkatesh, P.1    Mandal, S.2    Garg, S.3
  • 11
    • 77951173410 scopus 로고    scopus 로고
    • The effect of intravitreal bevacizumab in the treatment of Coats disease in children
    • Lin CJ, Hwang JF, Chen YT, Chen SN (2010) The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina 30:617-622
    • (2010) Retina , vol.30 , pp. 617-622
    • Lin, C.J.1    Hwang, J.F.2    Chen, Y.T.3    Chen, S.N.4
  • 12
    • 77649206199 scopus 로고    scopus 로고
    • Combined intravitreal bevacizumab and argon laser treatment for Coats' disease
    • Cackett P, Wong D, Cheung CM (2010) Combined intravitreal bevacizumab and argon laser treatment for Coats' disease. Acta Ophthalmol 88:e48-e49
    • (2010) Acta Ophthalmol , vol.88
    • Cackett, P.1    Wong, D.2    Cheung, C.M.3
  • 13
    • 73849109765 scopus 로고    scopus 로고
    • Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children
    • Kaul S, Uparkar M, Mody K, Walinjkar J, Kothari M, Natarajan S (2010) Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children. Indian J Ophthalmol 58:76-78
    • (2010) Indian J Ophthalmol , vol.58 , pp. 76-78
    • Kaul, S.1    Uparkar, M.2    Mody, K.3    Walinjkar, J.4    Kothari, M.5    Natarajan, S.6
  • 15
    • 56049093465 scopus 로고    scopus 로고
    • Resolution of severe macular edema in adult Coats' disease with intravitreal triamcinolone and bevacizumab injection
    • Jun JH, Kim YC, Kim KS (2008) Resolution of severe macular edema in adult Coats' disease with intravitreal triamcinolone and bevacizumab injection. Korean J Ophthalmol 22:190-193
    • (2008) Korean J Ophthalmol , vol.22 , pp. 190-193
    • Jun, J.H.1    Kim, Y.C.2    Kim, K.S.3
  • 17
    • 34548022138 scopus 로고    scopus 로고
    • Elevated vascular endothelial growth factor levels in Coats disease: Rapid response to pegaptanib sodium
    • DOI 10.1007/s00417-007-0559-8
    • Sun Y, Jain A, Moshfeghin DM (2007) Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefe's Arch Clin Exp Ophthalmol 245:1387-1388 (Pubitemid 47278676)
    • (2007) Graefe's Archive for Clinical and Experimental Ophthalmology , vol.245 , Issue.9 , pp. 1387-1388
    • Sun, Y.1    Jain, A.2    Moshfeghi, D.M.3
  • 18
    • 77956189058 scopus 로고    scopus 로고
    • Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab
    • He YG, Wang H, Zhao B, Lee J, Bahl D, McCluskey J (2010) Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol 248(10): 1519-1521
    • (2010) Graefes Arch Clin Exp Ophthalmol , vol.248 , Issue.10 , pp. 1519-1521
    • He, Y.G.1    Wang, H.2    Zhao, B.3    Lee, J.4    Bahl, D.5    McCluskey, J.6
  • 19
    • 52949113486 scopus 로고    scopus 로고
    • Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
    • Tübingen Bevacizumab Study Group
    • Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Tübingen Bevacizumab Study Group, Grisanti S (2008) Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology 115:1750-1755
    • (2008) Ophthalmology , vol.115 , pp. 1750-1755
    • Zhu, Q.1    Ziemssen, F.2    Henke-Fahle, S.3    Tatar, O.4    Szurman, P.5    Aisenbrey, S.6    Schneiderhan-Marra, N.7    Xu, X.8    Grisanti, S.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.